Monalizumab

Vendor: Abmole

Type: Antibodies

SKU: M21501

Explore specifications & documents
$563.50 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

Request a quotation
  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.
Monalizumab

Monalizumab

$563.50 USD

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Monalizumab is a first-in-class immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab can be used in the study of head and neck squamous cell carcinoma (HNSCC).
Casnumber
1228763-95-8
Purity
>99%
Target synonyms
IPH2201
Technical documents

Documents

Coa

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab